{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:43:28Z","timestamp":1791193408230,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p>\n            This study examined the role of transforming growth factor-\u03b2 (TGF-\u03b2) in altering the glomerular permeability to albumin (P\n            <jats:sub>alb<\/jats:sub>\n            ) during hypertension development in Dahl salt-sensitive (Dahl S) rats and whether TGF-\u03b2 acts by inhibiting the glomerular production of 20-HETE. The results indicate that the renal expression of TGF-\u03b2 doubles in Dahl S rats fed a high-salt diet for 7 days, and this is associated with a marked rise in P\n            <jats:sub>alb<\/jats:sub>\n            from 0.19\u00b10.04 to 0.75\u00b10.01 and changes in the ultrastructure of the glomerular filtration barrier. Chronic treatment of Dahl S rats with a TGF-\u03b2 neutralizing antibody prevented the increase in P\n            <jats:sub>alb<\/jats:sub>\n            and preserved the structure of glomerular capillaries. It had no effect on the rise in blood pressure produced by the high-salt diet. In other studies, preincubation of glomeruli isolated from Sprague Dawley rats with TGF-\u03b21 (10 ng\/mL) for 15 minutes increased P\n            <jats:sub>alb<\/jats:sub>\n            from 0.01\u00b10.01 to 0.60\u00b10.02. This was associated with inhibition of the glomerular production of 20-HETE from 221\u00b111 to 3.4\u00b10.5 \u03bcg per 30 minutes per milligram of protein. Pretreatment of Sprague Dawley glomeruli with a stable analog of 20-HETE, 20-hydroxyeicosa-5(Z), 14(Z)-dienoic acid, reduced baseline P\n            <jats:sub>alb<\/jats:sub>\n            and opposed the effects of TGF-\u03b2 to increase P\n            <jats:sub>alb<\/jats:sub>\n            . These studies indicate that upregulation of the glomerular formation of TGF-\u03b2 may contribute to the development of proteinuria and glomerular injury early in hypertension development in Dahl S rats by increasing P\n            <jats:sub>alb<\/jats:sub>\n            through inhibition of the glomerular production of 20-HETE.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000153791.89776.43","type":"journal-article","created":{"date-parts":[[2005,2,22]],"date-time":"2005-02-22T01:14:26Z","timestamp":1109034866000},"page":"643-648","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":60,"title":["Transforming Growth Factor-\u03b2, 20-HETE Interaction, and Glomerular Injury in Dahl Salt-Sensitive Rats"],"prefix":"10.1161","volume":"45","author":[{"given":"Annette J.","family":"Dahly-Vernon","sequence":"first","affiliation":[{"name":"From the Departments of Physiology, Medicine, and Kidney Disease Center (A.J.D.-V., M.S., E.T.M., V.J.S., R.J.R.), Medical College of Wisconsin, Milwaukee; and Genzyme Corporation (S.R.L.), Framingham, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukut","family":"Sharma","sequence":"additional","affiliation":[{"name":"From the Departments of Physiology, Medicine, and Kidney Disease Center (A.J.D.-V., M.S., E.T.M., V.J.S., R.J.R.), Medical College of Wisconsin, Milwaukee; and Genzyme Corporation (S.R.L.), Framingham, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen T.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"From the Departments of Physiology, Medicine, and Kidney Disease Center (A.J.D.-V., M.S., E.T.M., V.J.S., R.J.R.), Medical College of Wisconsin, Milwaukee; and Genzyme Corporation (S.R.L.), Framingham, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia J.","family":"Savin","sequence":"additional","affiliation":[{"name":"From the Departments of Physiology, Medicine, and Kidney Disease Center (A.J.D.-V., M.S., E.T.M., V.J.S., R.J.R.), Medical College of Wisconsin, Milwaukee; and Genzyme Corporation (S.R.L.), Framingham, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Ledbetter","sequence":"additional","affiliation":[{"name":"From the Departments of Physiology, Medicine, and Kidney Disease Center (A.J.D.-V., M.S., E.T.M., V.J.S., R.J.R.), Medical College of Wisconsin, Milwaukee; and Genzyme Corporation (S.R.L.), Framingham, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[{"name":"From the Departments of Physiology, Medicine, and Kidney Disease Center (A.J.D.-V., M.S., E.T.M., V.J.S., R.J.R.), Medical College of Wisconsin, Milwaukee; and Genzyme Corporation (S.R.L.), Framingham, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","first-page":"531","volume":"78","year":"1994","unstructured":"Campese VM. Salt sensitivity in hypertension. Hypertension. 1994; 78: 531\u2013550.","journal-title":"Hypertension"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.15.6.803"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.9.1.18"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.4.6.753"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.18.5.630"},{"key":"e_1_3_2_6_2","first-page":"801","volume":"41","year":"1984","unstructured":"Raji L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984; 41: 801\u2013806.","journal-title":"Kidney Int"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.20.5.651"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.12.2.177"},{"key":"e_1_3_2_9_2","first-page":"985","volume":"21","year":"1988","unstructured":"Roman RJ, Ma YH, Frohkich B, Markham B. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension. 1988; 21: 985\u2013988.","journal-title":"Hypertension"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00077-0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.16.4.452"},{"key":"e_1_3_2_12_2","first-page":"285","volume":"12","year":"1987","unstructured":"McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive endstage renal disease are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis. 1987; 12: 285\u2013290.","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198205273062106"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(89)80006-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00098.2002"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00148.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200112367"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402088"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300777200"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2002"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311907"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000114022.20424.22"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.225"},{"key":"e_1_3_2_24_2","first-page":"S10.","volume":"18","year":"2000","unstructured":"Hoagland KM, Alonso-Galicia M, Fenoy FJ, Jacob HJ, Garret MR, Roman RJ. Altered blood pressure and renal function in chromosome 5 congenic Dahl salt-sensitive rats. J Hypertens. 2000; 18: S10.","journal-title":"J Hypertens"},{"key":"e_1_3_2_25_2","first-page":"2109","volume":"10","year":"1989","unstructured":"Dasch JR, Pace DR, Waegell W, Inenaga D, and Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-\u03b2. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol. 1989; 10: 2109\u20132119.","journal-title":"J Immunol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000120123.44945.47"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V361260"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1999.277.5.F790"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(03)00192-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V7122578"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000084634.97353.1a"},{"key":"e_1_3_2_32_2","first-page":"84A.","volume":"14","year":"2003","unstructured":"McCarthy ET, Sharma R, Roman RJ, Sharma M. 20-Hydroxyeicosatetraenoic acid (20-HETE) protects glomerular protein permeability barrier from focal segmental glomerulosclerosis (FGGS) factor. J Am Soc Nephrol. 2003; 14: 84A.","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.278.3.H769"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201x.2000.00668.x"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00068.x"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000047881.15426.dc"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1998.275.3.F370"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.279.1.H339"},{"key":"e_1_3_2_39_2","first-page":"2600","volume":"10","year":"2002","unstructured":"Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002; 10: 2600\u20132610.","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_2_40_2","first-page":"S99","volume":"87","year":"2003","unstructured":"August P, Suthanthiran M. Transforming growth factor beta and progression of renal disease. Kidney Int Suppl. 2003; 87: S99\u2013S104.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.278.3.C554"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00928.x"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000153791.89776.43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:42:54Z","timestamp":1715532174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000153791.89776.43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1161\/01.HYP.0000153791.89776.43"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000153791.89776.43","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"2004-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}